Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Polomar Health Services Q3 2026 Results: Net Loss of $514K, Loss Narrows

Polomar Health Services, Inc. reported a significant revenue increase to $3.74 million for the nine months ended September 30, 2026, compared to just $16,174 in the prior year period. Despite this growth, the company incurred a net loss of $829,002 and maintains a stockholders' deficit of $2.84 million, though it achieved positive cash flow from operations of $193,996.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1.10.0
Gross profit0.50.0
Net income-0.5-0.6
EPS (diluted, $ a share)$-0.02$-0.02

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+18296.5%
Gross margin45.4%
Operating margin-41.3%
Source

10-Q filed with the SEC, OTC: PMHS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Polomar Health Services, Inc.: key numbers

Share price
$0.1250Close, Nov 13
Market cap
$3.55M
Shares outstanding
28.38MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Polomar Health Services, Inc.

All →
5:22 PM ET 8-K
Loan & Debt

Polomar Health Services Debt Financing Update with Island 40 Group, LLC

Polomar Health Services executed a $450,000 promissory note and loan agreement with Island 40 Group, LLC to settle outstanding commissions owed for sales and distribution services. The note bears an initial 10% interest rate and is guaranteed by the company's wholly owned subsidiary, Polomar Specialty Pharmacy, LLC. The debt matures on March 31, 2027, and represents the formalization of a direct financial obligation for past services.

Counterparty
Island 40 Group, LLC
Term
through March 31, 2027
4:42 PM ET 8-K
Other 8-K Filing

Polomar Health Services Other 8-K Filing

Polomar Health Services announced that its financial statements for the first and second quarters of 2026 can no longer be relied upon due to accounting errors. The company identified unrecorded expenses, revenue recognition issues, and the misclassification of preferred stock, which are expected to increase its aggregate net loss by approximately $421,000. Polomar intends to restate these periods and expects to report one or more material weaknesses in its internal controls.

4:05 PM ET 8-K
Leadership Change

Polomar Health Services Leadership Change

Alexandra Peterson and Gabrielle Toledano resigned from the Board of Directors of Polomar Health Services, Inc., effective October 14, 2026. Following these departures, the Board reduced its size from five to three directors. The company stated the resignations were not due to any disagreements regarding operations, policies, or practices.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.